We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
-1.89%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$154M
AUM Growth
-$90.8M
Cap. Flow
-$89.2M
Cap. Flow %
-57.92%
Top 10 Hldgs %
20.11%
Holding
827
New
297
Increased
13
Reduced
39
Closed
409

Sector Composition

Rank Sector Weight
1 Financials 21.13%
2 Technology 16.45%
3 Healthcare 14.29%
4 Industrials 11.13%
5 Consumer Discretionary 10.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APGE icon
376
Apogee Therapeutics
APGE
$10.1B
-1,604
Closed -$72.7K
APH icon
377
Amphenol
APH
$185B
-16,758
Closed -$1.16M
APLE icon
378
Apple Hospitality REIT
APLE
$3.97B
-11,521
Closed -$177K
APLS
379
DELISTED
Apellis Pharmaceuticals
APLS
-10,680
Closed -$341K
APO icon
380
Apollo Global Management
APO
$69B
-7,943
Closed -$1.31M
APP icon
381
Applovin
APP
$134B
-6,927
Closed -$2.24M
ARCC icon
382
Ares Capital
ARCC
$13.4B
-32,956
Closed -$721K
ARCT icon
383
Arcturus Therapeutics
ARCT
$165M
-4,051
Closed -$68.7K
ARDC
384
Are Dynamic Credit Allocation Fund
ARDC
$295M
-47,060
Closed -$711K
ARDX icon
385
Ardelyx
ARDX
$1.24B
-66,728
Closed -$338K
ARLP icon
386
Alliance Resource Partners
ARLP
$3.34B
-7,278
Closed -$191K
ARVN icon
387
Arvinas
ARVN
$530M
-3,601
Closed -$69K
ARWR icon
388
Arrowhead Research
ARWR
$12.1B
-3,211
Closed -$60.4K
ASND icon
389
Ascendis Pharma A/S
ASND
$16.5B
-2,676
Closed -$368K
ATXS
390
DELISTED
Astria Therapeutics
ATXS
-7,247
Closed -$64.8K
AUPH icon
391
Aurinia Pharmaceuticals
AUPH
$1.95B
-36,084
Closed -$324K
AUTL
392
Autolus Therapeutics
AUTL
$389M
-26,429
Closed -$62.1K
AVA icon
393
Avista
AVA
$3.43B
-4,616
Closed -$169K
AXON
394
Axon Enterprise
AXON
$42.8B
-2,588
Closed -$1.54M
AXP icon
395
American Express
AXP
$224B
-4,244
Closed -$1.26M
AXSM icon
396
Axsome Therapeutics
AXSM
$11.7B
-3,705
Closed -$313K
BBDC icon
397
Barings BDC
BBDC
$869M
-81,557
Closed -$781K
BBIO icon
398
BridgeBio Pharma
BBIO
$16.4B
-12,637
Closed -$347K
BCRX icon
399
BioCryst Pharmaceuticals
BCRX
$2.42B
-46,007
Closed -$346K
BCSF icon
400
Bain Capital Specialty
BCSF
$821M
-46,020
Closed -$806K

Similar funds

Virtus ETF Advisers's Q1 2025 Portfolio in Review

As of Q1 2025, Virtus ETF Advisers held 827 positions worth $154M, down 37% from $245M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Virtus ETF Advisers withdrew a net $89.2M in Q1 2025, closing 409 positions and reducing 39 holdings. Its most notable exit was OFS Credit Co, an estimated $2.26M position sold in full.

By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 29% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Virtus ETF Advisers opened a new position in ICICI Bank worth $8.23M.

  • Virtus ETF Advisers's largest Q1 2025 buy was ICICI Bank: 261,046 shares worth $8.23M.
  • Virtus ETF Advisers added most to Microsoft in Q1 2025, an estimated $1.1M increase.
  • Virtus ETF Advisers's biggest Q1 2025 reduction was Fortinet, cutting an estimated $1.33M.
  • Virtus ETF Advisers fully exited OFS Credit Co in Q1 2025, selling an estimated $2.26M.
  • Virtus ETF Advisers's ten largest holdings make up 20% of its $154M portfolio in Q1 2025.
  • Virtus ETF Advisers opened 297 new positions and closed 409 in Q1 2025.
  • Virtus ETF Advisers's portfolio value fell 37% quarter-over-quarter to $154M.

Based on Virtus ETF Advisers's 13F filing for Q1 2025, filed 14 May 2025.